$RDGL

VIVOS INC (RDGL): Entry into a Material Definitive Agreement

VIVOS INC (RDGL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 7, 2026, the Company entered into a Stock Purchase and Exchange Agreement (the “ Exchange Agreement ”), with a member of its Board of Directors (the “ Director ”). Pursuant to the Exchange Agreement, the Director ag

Original reporting
Published Oct 8, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$RDGL
Neutral
high confidence
Mentioned
$RDGL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RDGLNeutralLow
01

Why it matters

The transaction introduces new preferred equity, modestly diluting existing shareholders and may affect conversion dynamics, but the cash component is small.

02

Market read

A micro‑cap corporate financing event with limited broader market impact.

03

What to watch

Potential future financing terms attached to the preferred shares and any covenants that may affect future capital raises.

Relevance 6/10Novelty 5/10Timing: same day filing

Background

The 8‑K filing details a material definitive agreement involving the issuance and exchange of preferred securities, a routine financing move for a micro‑cap.

Company-level read

Ticker impact

$RDGLNeutralHigh confidence
Context

VIVOS Inc filed an 8‑K reporting a stock purchase and exchange of preferred shares with a director, creating 635,302 Series D Preferred shares and eliminating Series C Preferred.

Expected impact

likely slight pressure as the market prices in the new preferred shares and dilution

Evidence & confidence

The filing discloses a $250,000 purchase of preferred stock and a share exchange, a material corporate action for a micro‑cap, but the amount is modest and no immediate cash inflow is reported.

Market effects

Limited impact; preferred‑stock transactions are common in small‑cap biotech/tech financing and do not signal sector‑wide trends.

None

None

Counterpoint

If the preferred shares convert at a low price ($0.08), they could become a catalyst for upside if the company raises equity at higher valuations.

Key entities

  • VIVOS Inc

    Issuer of the Series D Preferred shares.

  • Director (Carl Cadwell)

    Board member participating in the share exchange.

Related articles

$CVIMedAI 8/10

CVR Energy Starts $750 Mln Public Offering; Shares Down

CVR Energy (CVI) launched a $750 million public offering of common stock, with $500 million from the company and $250 million from its controlling shareholder. Proceeds will fund a refinery acquisition, redeem senior notes, and cover costs. Shares fell 12.12% to $49.14.

$ABRHighAI 8/10

Arbor Realty Suspends Its Dividend as Shares Plunge 73% in 2026

Arbor Realty Trust (ABR) suspended its common dividend, saving $125M annually. Shares fell 35.3% last week and 73.4% YTD. CEO Kaufman cited rising 10-year Treasury yields and declining property values. CFO Elenio reported distributable earnings of $0.08/share and book value of $10.92/share. Non-performing loans increased to $647.6M. Peers BXMT and STWD have cut or maintained dividends, with smaller YTD declines.

$ORCLHigh

Oracle Makes Massive $20 Billion AI Funding Move

Oracle (ORCL) raised $20 billion via stock and bond offerings to fund AI and cloud expansion. It sold 86.2 million shares at $116 each, an 11.2% discount, and issued bonds with rates between 7% and 8.65%. Shares fell 8.8%, extending their year-to-date decline to 39%. Oracle aims for $225 billion in revenue by 2030 and expects positive free cash flow by fiscal 2028.